R&D Highlights of 2015 - The Five Big Drug Stories Of The Year
This article was originally published in Scrip
Executive Summary
2015 may have been the year when immune-oncology dominated the R&D headlines, but there were other products that caught Scrip's readers' interest during the 12 months for reasons both good and bad – here are five of the most-read topics.